Holdings: Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial

Background Few randomised clinical trials have investigated the use of antithrombotic drugs for early secondary prevention of stroke or transient ischaemic attack in patients with intracranial atherosclerotic stenosis. Microembolic signals, detected by transcranial doppler, are a surrogate marker of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wong, K.S.L., Chen, C., Fu, J., Chang, H.M., Suwanwela, N.C., Huang, Y.N., Han, Z., Tan, K.S., Ratanakorn, D., Chollate, P., Zhao, Y., Koh, A., Hao, Q., Markus, H.S., Invest, CLAIR Study
Format:	Article
Published:	Elsevier 2010
Subjects:	Q Science (General)
Online Access:	http://eprints.um.edu.my/14729/
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

http://eprints.um.edu.my/14729/

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial

Internet

Similar Items